WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera (OTCBB:GTHA) announces that it has progressed with
negotiations with a leading Mexican University to develop a test and
vaccine for...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--In line with its strategic direction to commercialize a live animal test
for Johne’s Disease, GeneThera (OTCBB:GTHA)
announces the formation...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera, Inc. (OTCBB:GTHA) is pleased to update its shareholders with
this release announcing the continuation of work done earlier by the ...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera (OTCBB:GTHA) announces that it will be the main subject of a
Media Campaign being led by InvestInItaly.
InvestInItaly has...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera, Inc. (OTCBB:GTHA) announced today that Dr. Antonio Milici
M.D., Ph.D., CEO of GeneThera, Inc., will be live on Market News First (www.mn1.com)...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera, Inc. (OTCBB:GTHA) is pleased to announce the finalization,
subject to final translation, of a Collaboration Agreement with Italy’s ...
DALLAS--(BUSINESS WIRE)--Dr. Tony Milici, CEO of GeneThera, Inc. (OTCBB:GTHA.OB), spoke with
Research Analyst Mike Willingham from MN1.com in a recent press
conference. Willingham...
#12: GTHA News GeneThera Recaps Milestone Ladened Q3; BSE/Mad Cow Live Animal Testing Agreements Consummated; Transitions from Development Company to Revenue-Generating Commercial Enterprise
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--Oct. 24, 2005--GeneThera, Inc. (OTCBB:GTHA) is pleased to recap milestone achievements realized during the third quarter of 2005. As outlined in the company's...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--Sept. 14, 2005--In line with its strategic direction to commercialize a live animal test for Mad Cow Disease and several other veterinary diseases, GeneThera...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--Aug. 23, 2005--GeneThera, Inc. (OTCBB:GTHA), a molecular biotechnology company focused on the detection and treatment of disease in animals using...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--Aug. 16, 2005--GeneThera, Inc. (OTCBB:GTHA) announced today that it has narrowed its second quarter loss to $0.02 per share from prior year loss of $.70 per...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--July 25, 2005--In line with its strategic direction to commercialize a live animal test for several veterinary diseases, GeneThera (OTCBB:GTHA) announces its...
WHEAT RIDGE, Colo.--(BUSINESS WIRE)--July 19, 2005--GeneThera, Inc. (OTCBB:GTHA) is pleased to announce that with the signing of its first two contracts with Xpention Genetics, Inc. (OTCBB:XPNG),...
WHEAT RIDGE, Colorado--(BUSINESS WIRE)--11 juli, 2005-- GeneThera, Inc. (OTCBB:GTHA) heeft aan Beckman Coulter, Inc. (NYSE:BEC) de eerste optierechten voor het in licentie gebruiken van de...
